Tenax Therapeutics Inc (TENX) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Tenax Therapeutics Inc   (NASDAQ: TENX)


Tenax Therapeutics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Tenax Therapeutics Inc's ROI in the second quarter of 2026?
Tenax Therapeutics Inc recorded a cumulative net loss of $-65 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -61.55%.

Within the Healthcare sector 194 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3696 to 3747.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 4.91 % 33.81 % 92.81 % 216.54 % 887.54 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 114 115 97 96 103
Return On Investment (TTM) -61.55 % -56.32 % -51.83 % -30.73 % -18.86 %
TENX's Overall Ranking # 3747 # 3696 # 2655 # 3220 # 2525
Seq. Investment Change TTM 2.49 % 1.33 % 1.27 % -0.25 % 30.73 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -65 -58 -53 -31 -19

TENX Company Profile >> Back to TENX Roi Comparisons >> See Annual TENX Return On Investment



Return On Investment TENX's Ranking
Within: No.
Industry # 69
Sector # 195
Overall # 3747

Return On Investment Statistics
High Average Low
1477.67 %
118.92 %
-1394.18 %
(Jan 31 2014)   (Mar 31 2022)



  News about Tenax Therapeutics Inc Return on Investment ROI

Tenax Therapeutics Expands Global Rights to Revolutionary Treatment for Pulmonary Hypertension

February 20, 2024



In a major breakthrough for the field of cardiovascular and pulmonary medicine, Tenax Therapeutics, a Phase 3, development-stage pharmaceutical company, has announced a significant expansion of its global development, commercial, and intellectual property rights to a life-changing treatment known as levosimendan. This development holds immense promise for patients suffering from pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF).
Levosimendan, available in both oral and subcutaneous forms, has shown tremendous potential in addressing the high unmet medical need for this particular condition. This exciting announcement comes as Tenax Therapeutics Inc. shares traded just 5.6% above their 52-week low, reflecting the immense potential for growth and impact in the coming months.





Financial Statements
Tenax Therapeutics Inc's II. Quarter Investments $ 114 Millions TENX's Balance sheet
Tenax Therapeutics Inc's II. Quarter Income $ -18 Millions Quarterly TENX's Income Statement
TENX's Income by Division See TENX's Income by Division


TENX Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 97 92 8 2 4
Y / Y Investment Growth 5.52 % 1035.98 % 282.52 % -52.19 % -6.77 %
Net Income in Millions -53 18 8 11 -32
Y / Y Net Income Growth - 128.28 % -30.21 % - -
Annual Return On Investment -54.19 % 19.13 % 95.22 % 521.86 % -733.35 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
TENX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for TENX's Competitors
Subscribers only: Roi for Tenax Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for TENX's Customers

Other Ratios
TENX's Roa TENX's Inventory Turnover Ratio TENX's Growth Rates TENX's Dividend Statistics
TENX's Profitability Ratios TENX's Asset Turnover Ratio TENX's Dividend Growth
TENX's Roe TENX's Valuation Ratios TENX's Financial Strength Ratios TENX's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-08-13T17:55:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.